Elikim Bio-Pharmaceuticals LLC - GA DeKalb, Decatur 30034

Elikim Bio-Pharmaceuticals LLC entered the industry of Commercial Biotechnical Research in 2007 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Elikim Shabazz by calling (480) 891-3000 during business hours. You can also write to the business’ Single Location at 3371 Comet Circle, Decatur, Georgia GA 30034. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Elikim Bio-Pharmaceuticals LLC
Representative: Elikim Shabazz
Place of Business: 3371 Comet Circle, Decatur, GA 30034
Contact Number: (480) 891-3000
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2007
Income/Year: $50.000 to $99.999
Laborers: 1 to 4
Share This Company:

Elikim Bio-Pharmaceuticals LLC is a company operating from DeKalb, Georgia providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2007 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Elikim Bio-Pharmaceuticals LLC has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Elikim Shabazz at (480) 891-3000 for related queries, or to locate its Single Location using the coordinates 33.710663,-84.250602.

The Single Location can also be found at the street address 3371 Comet Circle in Decatur, Georgia 30034 and can be engaged online through the company website at , the company Twitter , and Facebook page .